125 related articles for article (PubMed ID: 34100663)
1. Attenuation by HSP90 inhibitors of EGF-elicited migration of osteoblasts: involvement of p44/p42 MAP kinase.
Kuroyanagi G; Kawabata T; Tokuda H; Fujita K; Matsushima-Nishiwaki R; Sakai G; Tachi J; Hioki T; Kim W; Iida H; Otsuka T; Kozawa O
Connect Tissue Res; 2022 Jul; 63(4):359-369. PubMed ID: 34100663
[TBL] [Abstract][Full Text] [Related]
2. HSP90 inhibitors diminish PDGF-BB-induced migration of osteoblasts via suppression of p44/p42 MAP kinase.
Kawabata T; Tokuda H; Fujita K; Matsushima-Nishiwaki R; Sakai G; Tachi J; Hioki T; Kim W; Iida H; Otsuka T; Kozawa O
Biomed Res; 2019; 40(4):169-178. PubMed ID: 31413238
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of TGF-β-induced HSP27 by HSP90 inhibitors in osteoblasts.
Kuroyanagi G; Tokuda H; Fujita K; Kawabata T; Sakai G; Kim W; Hioki T; Tachi J; Matsushima-Nishiwaki R; Otsuka T; Iida H; Kozawa O
BMC Musculoskelet Disord; 2022 May; 23(1):495. PubMed ID: 35619094
[TBL] [Abstract][Full Text] [Related]
4. HSP70 Inhibitors Reduce The Osteoblast Migration By Epidermal Growth Factor.
Kawabata T; Otsuka T; Fujita K; Sakai G; Kim W; Matsushima-Nishiwaki R; Kuroyanagi G; Kozawa O; Tokuda H
Curr Mol Med; 2018; 18(7):486-495. PubMed ID: 30543167
[TBL] [Abstract][Full Text] [Related]
5. HSP90 inhibitors strengthen extracellular ATP-stimulated synthesis of interleukin-6 in osteoblasts: Amplification of p38 MAP kinase.
Hioki T; Tokuda H; Nakashima D; Fujita K; Kawabata T; Sakai G; Kim W; Tachi J; Tanabe K; Matsushima-Nishiwaki R; Otsuka T; Iida H; Kozawa O
Cell Biochem Funct; 2021 Jan; 39(1):88-97. PubMed ID: 32567086
[TBL] [Abstract][Full Text] [Related]
6. HSP90 inhibitors potentiate PGF2α-induced IL-6 synthesis via p38 MAP kinase in osteoblasts.
Fujita K; Tokuda H; Kuroyanagi G; Yamamoto N; Kainuma S; Kawabata T; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
PLoS One; 2017; 12(5):e0177878. PubMed ID: 28542188
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol Inhibits the Epidermal Growth Factor-Induced Migration of Osteoblasts: the Suppression of SAPK/JNK and Akt.
Kawabata T; Tokuda H; Fujita K; Kainuma S; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
Cell Physiol Biochem; 2017; 43(3):1025-1036. PubMed ID: 28968596
[TBL] [Abstract][Full Text] [Related]
8. Enhancement by HSP90 inhibitor of PGD2-stimulated HSP27 induction in osteoblasts: Suppression of SAPK/JNK and p38 MAP kinase.
Kim W; Tokuda H; Kawabata T; Fujita K; Sakai G; Nakashima D; Tachi J; Kuroyanagi G; Matsushima-Nishiwaki R; Tanabe K; Otsuka T; Iida H; Kozawa O
Prostaglandins Other Lipid Mediat; 2019 Aug; 143():106327. PubMed ID: 30946899
[TBL] [Abstract][Full Text] [Related]
9. Involvement of p44/p42 MAP kinase in insulin-like growth factor-I-induced alkaline phosphatase activity in osteoblast-like-MC3T3-E1 cells.
Hanai Y; Tokuda H; Ishisaki A; Matsushima-Nishiwaki R; Nakamura N; Yoshida M; Takai S; Ohta T; Kozawa O
Mol Cell Endocrinol; 2006 Jun; 251(1-2):42-8. PubMed ID: 16616413
[TBL] [Abstract][Full Text] [Related]
10. Involvement of stress-activated protein kinase (SAPK)/c-Jun N-terminal kinase (JNK) in prostaglandin F2alpha-induced heat shock protein 27 in osteoblasts.
Tokuda H; Niwa M; Ishisaki A; Nakajima K; Ito H; Kato K; Kozawa O
Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):441-7. PubMed ID: 15062846
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol suppresses insulin-like growth factor I-induced osteoblast migration: attenuation of the p44/p42 MAP kinase pathway.
Hioki T; Kawabata T; Sakai G; Fujita K; Kuroyanagi G; Matsushima-Nishiwaki R; Kim W; Otsuka T; Iida H; Tokuda H; Kozawa O
Biosci Biotechnol Biochem; 2020 Dec; 84(12):2428-2439. PubMed ID: 32862787
[TBL] [Abstract][Full Text] [Related]
12. Mitogen-activated protein (MAP) kinases are involved in interleukin-1 (IL-1)-induced IL-6 synthesis in osteoblasts: modulation not of p38 MAP kinase, but of p42/p44 MAP kinase by IL-1-activated protein kinase C.
Miwa M; Kozawa O; Tokuda H; Uematsu T
Endocrinology; 1999 Nov; 140(11):5120-5. PubMed ID: 10537140
[TBL] [Abstract][Full Text] [Related]
13. Involvement of SAPK/JNK in basic fibroblast growth factor-induced vascular endothelial growth factor release in osteoblasts.
Tokuda H; Hirade K; Wang X; Oiso Y; Kozawa O
J Endocrinol; 2003 Apr; 177(1):101-7. PubMed ID: 12697041
[TBL] [Abstract][Full Text] [Related]
14. Involvement of AMP-activated protein kinase in thrombin-stimulated interleukin 6 synthesis in osteoblasts.
Tokuda H; Kato K; Natsume H; Kondo A; Kuroyanagi G; Matsushima-Nishiwaki R; Ito Y; Otsuka T; Kozawa O
J Mol Endocrinol; 2012 Aug; 49(1):47-55. PubMed ID: 22645249
[TBL] [Abstract][Full Text] [Related]
15. HSP70 Inhibitor Suppresses IGF-I-Stimulated Migration of Osteoblasts through p44/p42 MAP Kinase.
Kawabata T; Tokuda H; Sakai G; Fujita K; Matsushima-Nishiwaki R; Kuroyanagi G; Otsuka T; Kozawa O
Biomedicines; 2018 Nov; 6(4):. PubMed ID: 30469446
[TBL] [Abstract][Full Text] [Related]
16. Basic fibroblast growth factor stimulates vascular endothelial growth factor release in osteoblasts: divergent regulation by p42/p44 mitogen-activated protein kinase and p38 mitogen-activated protein kinase.
Tokuda H; Kozawa O; Uematsu T
J Bone Miner Res; 2000 Dec; 15(12):2371-9. PubMed ID: 11127202
[TBL] [Abstract][Full Text] [Related]
17. Divergent regulation by p44/p42 MAP kinase and p38 MAP kinase of bone morphogenetic protein-4-stimulated osteocalcin synthesis in osteoblasts.
Kozawa O; Hatakeyama D; Uematsu T
J Cell Biochem; 2002; 84(3):583-9. PubMed ID: 11813263
[TBL] [Abstract][Full Text] [Related]
18. Involvement of SAPK/JNK in prostaglandin E(1)-induced VEGF synthesis in osteoblast-like cells.
Kanno Y; Tokuda H; Nakajima K; Ishisaki A; Shibata T; Numata O; Kozawa O
Mol Cell Endocrinol; 2004 May; 220(1-2):89-95. PubMed ID: 15196703
[TBL] [Abstract][Full Text] [Related]
19. Oncostatin M stimulates prostaglandin D
Kuroyanagi G; Hioki T; Tachi J; Matsushima-Nishiwaki R; Iida H; Kozawa O; Tokuda H
Prostaglandins Leukot Essent Fatty Acids; 2023 May; 192():102575. PubMed ID: 37094446
[TBL] [Abstract][Full Text] [Related]
20. Oncostatin M attenuates tumor necrosis factor-α-induced synthesis of macrophage-colony stimulating factor via suppression of Akt in osteoblasts.
Hioki T; Kuroyanagi G; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Connect Tissue Res; 2023 Mar; 64(2):139-147. PubMed ID: 35986560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
